CD226 and acute myeloid leukemia: When comparing between AML patients and healthy donors, the results show that the percentage of CD4+ and CD8+ T cells expressing DNAM-1+ was significantly reduced in AML patients, whereas the percentages of TACTILE+ cells and TIGIT+ cells were preserved (Figure 4a–d).